Kyle Woodley

Kyle Woodley

Senior Investing Editor, Kiplinger

Kyle Woodley is the Senior Investing Editor of Kiplinger.com. His articles covering stock picks, exchange-traded funds and mutual funds have been featured on MSN, Nasdaq and U.S. News & World Report. He also has appeared on Fox Business Network.

He previously was Managing Editor of InvestorPlace.com, and an award-winning designer and copy editor with Gannett. He also is a graduate of Ohio State University.

Kyle can be reached at kwoodley@kiplinger.com, or you can follow him on Twitter at @KyleWoodley.

Recent Articles

Forget Earnings — For DFS, It’s All About the Fiscal Cliff

By Kyle Woodley, Senior Investing Editor, Kiplinger

All things being equal, quarterly numbers don't tend to move Discover much. Here's what DFS investors should consider instead.

Biotech Movers: Acadia Rockets on Trial News

By Kyle Woodley, Senior Investing Editor, Kiplinger

Acadia Pharmaceuticals leads the way with a week of eye-popping gains. Plus: Why Exelixis and Supernus took tough tumbles.

5 Retail ETFs to Browse Before Black Friday

By Kyle Woodley, Senior Investing Editor, Kiplinger

All signs point to a golden Q4 for retailers, so consider a broad bet on the sector through one or more of these five retail ETFs.

The Lowdown on LOW Pricing

By Kyle Woodley, Senior Investing Editor, Kiplinger

Lowe's soars with 'everyday low pricing' while JCPenney falters -- but then, the home-improvement retailer has a strong tailwind that the apparel play doesn't.

Biotech Movers: Regeneron Pops, 3 Flop

By Kyle Woodley, Senior Investing Editor, Kiplinger

While Regeneron soared on behind its macular degeneration treatment, Dynavax, Navidea and AspenBio suffered serious setbacks.

Load More